Do we need endothelin antagonists?

Suppr

超能文献

作者信息

Lüscher T F

机构信息

Division of Cardiology, University Hospital, Berne, Switzerland.

出版信息

Cardiovasc Res. 1993 Dec;27(12):2089-93. doi: 10.1093/cvr/27.12.2089.

DOI:10.1093/cvr/27.12.2089

PMID:8313411

Abstract

摘要

相似文献

Do we need endothelin antagonists?

Cardiovasc Res. 1993 Dec;27(12):2089-93. doi: 10.1093/cvr/27.12.2089.

[The role of endothelins in human cardiovascular disease].[内皮素在人类心血管疾病中的作用]

Pol Merkur Lekarski. 2001 Nov;11(65):444-6.

Inhibitors of endothelin.

Med Res Rev. 1997 Jan;17(1):17-67. doi: 10.1002/(sici)1098-1128(199701)17:1<17::aid-med2>3.0.co;2-w.

[Endothelin---biosynthesis, function and role in cardiovascular diseases].

Pol Arch Med Wewn. 2002 Jul;108(1):703-14.

Endothelin.

Am J Physiol Regul Integr Comp Physiol. 2003 Aug;285(2):R298-301. doi: 10.1152/ajpregu.00249.2003.

Endothelin as a therapeutic target in the treatment of cardiovascular disease.

Heart Dis. 2001 May-Jun;3(3):176-88. doi: 10.1097/00132580-200105000-00008.

Endothelin receptor subtypes and their role in transmembrane signaling mechanisms.内皮素受体亚型及其在跨膜信号传导机制中的作用。

Pharmacol Ther. 1995;68(3):435-71. doi: 10.1016/0163-7258(95)02015-2.

[Endothelin].

No Shinkei Geka. 1990 Sep;18(9):797-806.

Vasoactive peptides, their receptors and drug development.血管活性肽、其受体与药物研发

Basic Clin Pharmacol Toxicol. 2004 Jan;94(1):5-12.

Endothelin peptides.

Curr Opin Nephrol Hypertens. 1996 Jan;5(1):12-5. doi: 10.1097/00041552-199601000-00004.

引用本文的文献

Control of coronary blood flow by autacoids.自分泌调节物对冠状动脉血流的调控

Basic Res Cardiol. 1995 Mar-Apr;90(2):125-41. doi: 10.1007/BF00789443.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

Do we need endothelin antagonists?

Cardiovasc Res. 1993 Dec;27(12):2089-93. doi: 10.1093/cvr/27.12.2089.

[The role of endothelins in human cardiovascular disease].[内皮素在人类心血管疾病中的作用]

Pol Merkur Lekarski. 2001 Nov;11(65):444-6.

Inhibitors of endothelin.

Med Res Rev. 1997 Jan;17(1):17-67. doi: 10.1002/(sici)1098-1128(199701)17:1<17::aid-med2>3.0.co;2-w.

[Endothelin---biosynthesis, function and role in cardiovascular diseases].

Pol Arch Med Wewn. 2002 Jul;108(1):703-14.

Endothelin.

Am J Physiol Regul Integr Comp Physiol. 2003 Aug;285(2):R298-301. doi: 10.1152/ajpregu.00249.2003.

Endothelin as a therapeutic target in the treatment of cardiovascular disease.

Heart Dis. 2001 May-Jun;3(3):176-88. doi: 10.1097/00132580-200105000-00008.

Endothelin receptor subtypes and their role in transmembrane signaling mechanisms.内皮素受体亚型及其在跨膜信号传导机制中的作用。

Pharmacol Ther. 1995;68(3):435-71. doi: 10.1016/0163-7258(95)02015-2.

[Endothelin].

No Shinkei Geka. 1990 Sep;18(9):797-806.

Vasoactive peptides, their receptors and drug development.血管活性肽、其受体与药物研发

Basic Clin Pharmacol Toxicol. 2004 Jan;94(1):5-12.

Endothelin peptides.

Curr Opin Nephrol Hypertens. 1996 Jan;5(1):12-5. doi: 10.1097/00041552-199601000-00004.

引用本文的文献

Control of coronary blood flow by autacoids.自分泌调节物对冠状动脉血流的调控

Basic Res Cardiol. 1995 Mar-Apr;90(2):125-41. doi: 10.1007/BF00789443.